EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical

Improving Transition of Investigational Medicines in Alzheimer’s Disease From Phase I To Phase II


Improving Transition of Investigational Medicines in Alzheimer’s Disease From Phase I To Phase II

In January 2012, the Obama administration’s Presidential advisory group outlined an ambitious goal – to prevent and effectively treat Alzheimer’s disease (AD) by 2025, followed by the President signing the National Alzheimer’s Project Act, officially declaring a “War on Alzheimer’s disease”. Stanford Jhee and his team at PAREXEL International discuss how the initiative to increase funding into AD prevention and treatment was driven by the looming AD “epidemic” projected to increase direct costs of AD from $200 billion to $1.1 trillion by 2050.
http://jforcs.com/jcs/wp-content/uploads/2013/02/Improving-Transition-of-Investigational-Medicines-in-Alzheimers-Disease-from-Phase-I-to-Phase-II.pdf
 
 

Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18